116 related articles for article (PubMed ID: 6658866)
1. Decreased serum 19-nor-deoxycorticosterone (21-hydroxy-19-nor-4-pregnene-3, 20-dione) level in adrenal regeneration hypertensive rats.
Saeki S; Ogihara T; Kumahara Y; Kobayashi Y; Yamamura Y; Watanabe F
Steroids; 1983 Jan; 41(1):99-104. PubMed ID: 6658866
[TBL] [Abstract][Full Text] [Related]
2. Role of adrenal steroidogenesis in etiology of hypertension in the spontaneously hypertensive rat.
Komanicky P; Reiss DL; Dale SL; Melby JC
Endocrinology; 1982 Jul; 111(1):219-24. PubMed ID: 7084111
[TBL] [Abstract][Full Text] [Related]
3. Urinary free and serum 19-nor-deoxycorticosterone in adrenal regeneration hypertension.
Gomez-Sanchez CE; Gomez-Sanchez EP; Upcavage RJ; Hall EB
Hypertension; 1983; 5(2 Pt 2):I32-4. PubMed ID: 6826226
[No Abstract] [Full Text] [Related]
4. Effects of adrenalectomy and nephrectomy on adrenal regeneration hypertension in the rat.
Chan JY; Chan SH
Proc Natl Sci Counc Repub China B; 1991 Oct; 15(4):197-205. PubMed ID: 1815260
[TBL] [Abstract][Full Text] [Related]
5. Adrenal mitochondrial and serum corticosteroid studies in rats resistant to adrenal-regeneration hypertension (ARH).
Bergon L; Brownie AC
Endocrinology; 1976 Oct; 99(4):1080-4. PubMed ID: 976188
[TBL] [Abstract][Full Text] [Related]
6. Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione.
Griffing GT; Holbrook M; Melby JC; Brodie AH
Clin Physiol Biochem; 1988; 6(3-4):171-8. PubMed ID: 3203487
[TBL] [Abstract][Full Text] [Related]
7. Serum 11-deoxycorticosterone levels in adrenal-regeneration hypertension under conditions of quiescence and stress.
Bergon L; Gallant S; Brownie AC
Steroids; 1975 Mar; 25(3):323-42. PubMed ID: 1145670
[TBL] [Abstract][Full Text] [Related]
8. Identification of 19-nor-deoxycorticosterone in normal rat serum by enzyme immunoassay and gas chromatography-mass spectrometry.
Kobayashi Y; Ogihara T; Yamamura Y; Watanabe F; Kiguchi T; Ninomiya I; Kumahara Y
Endocrinol Jpn; 1984 Feb; 31(1):49-53. PubMed ID: 6376074
[TBL] [Abstract][Full Text] [Related]
9. 19-Nor-corticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR).
Melby JC; Dale SL; Holbrook M; Wilson TE; Griffing GT; Arison BH
Endocr Res; 1984-1985; 10(3-4):591-607. PubMed ID: 6336061
[TBL] [Abstract][Full Text] [Related]
10. Identification of 19-hydroxydeoxycorticosterone, 19-oxo-deoxycorticosterone, and 19-oic-deoxycorticosterone as products of deoxycorticosterone metabolism by rat adrenals.
Gomez-Sanchez CE; Gomez-Sanchez EP; Shackleton CH; Milewich L
Endocrinology; 1982 Feb; 110(2):384-9. PubMed ID: 7056205
[TBL] [Abstract][Full Text] [Related]
11. Deoxycorticosterone measured by a radioimmunoassay in vivo in rats undergoing adrenal regeneration.
Hauger-Klevene JH; Vecsei P
Clin Sci Mol Med Suppl; 1976 Dec; 3():299s-301s. PubMed ID: 1071630
[TBL] [Abstract][Full Text] [Related]
12. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27.
Sander M; Bader M; Djavidani B; Maser-Gluth C; Vecsei P; Mullins J; Ganten D; Peters J
Endocrinology; 1992 Aug; 131(2):807-14. PubMed ID: 1322284
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay for urinary free 19-nor-deoxycorticosterone: effects of adrenocorticotropin and sodium depletion.
Gomez-Sanchez CE; Gomez-Sanchez EP; Upcavage RJ
Endocrinology; 1983 Jun; 112(6):2046-9. PubMed ID: 6303757
[TBL] [Abstract][Full Text] [Related]
14. Resistance to mineralocorticoid-induced hypertensive vascular disease.
Sciotti V; Gallant S
Hypertension; 1987 Aug; 10(2):176-80. PubMed ID: 3610293
[TBL] [Abstract][Full Text] [Related]
15. Adrenal steroidogenesis in the spontaneously hypertensive rat (SHR).
Moll D; Dale SL; Melby JC
Endocrinology; 1975 Feb; 96(2):416-20. PubMed ID: 1116474
[TBL] [Abstract][Full Text] [Related]
16. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
[TBL] [Abstract][Full Text] [Related]
17. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
Melby JC; Dale SL
Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
[TBL] [Abstract][Full Text] [Related]
18. An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.
Griffing GT; Chobainian AV; Egdahl R; Ehlers ME; Melby JC
Clin Exp Hypertens A; 1989; 11(2):317-21. PubMed ID: 2650931
[TBL] [Abstract][Full Text] [Related]
19. Adrenal steroidogenesis in methylandrostenediol-induced hypertension.
McCall AL; Stern J; Dale SL; Melby JC
Endocrinology; 1978 Jul; 103(1):1-5. PubMed ID: 744061
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive rat.
Melby JC; Holbrook M; Griffing GT; Johnston JO
Hypertension; 1987 Nov; 10(5):484-7. PubMed ID: 3666863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
